Publisher： Bentham Science Publishers
E-ISSN： 1996-3181|9|6|791-800
ISSN： 1871-5273
Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.9, Iss.6, 2010-12, pp. : 791-800
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Effects of oxygen on kynurenine-3-monooxygenase activity
By Dang Y. Dale W.E. Brown O.R.
Redox Report, Vol. 5, Iss. 2-3, 2000-04 ,pp. :
Access to resources
Recommend
Combination therapy with olanzapine plus valproate: potential in Huntington's disease?
Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. :
Disease Modifying Agents for Huntington's Disease: What is on the Horizon?
CNS Drugs, Vol. 12, Iss. 5, 1999-11 ,pp. :